Bijo Mathew (M.Pharm., Ph.D.)
Bijo Mathew (M.Pharm., Ph.D.)
Associate Professor of Pharmaceutical Chemistry,Amrita School of Pharmacy,Amrita Vishwa Vidyapeetham
Verified email at aims.amrita.edu - Homepage
Title
Cited by
Cited by
Year
Development of fluorinated methoxylated chalcones as selective monoamine oxidase-B inhibitors: Synthesis, biochemistry and molecular docking studies
B Mathew, GE Mathew, G Uçar, I Baysal, J Suresh, JK Vilapurathu, ...
Bioorganic chemistry 62, 22-29, 2015
652015
Nanoparticles and its biomedical applications in health and diseases: special focus on drug delivery
N Zahin, R Anwar, D Tewari, MT Kabir, A Sajid, B Mathew, MS Uddin, ...
Environmental Science and Pollution Research, 1-18, 2019
592019
Emerging promise of sulforaphane-mediated Nrf2 signaling cascade against neurological disorders
MS Uddin, A Al Mamun, M Jakaria, S Thangapandiyan, J Ahmad, ...
Science of the Total Environment 707, 135624, 2020
572020
Nootropic and anti-Alzheimer’s actions of medicinal plants: molecular insight into therapeutic potential to alleviate Alzheimer’s neuropathology
MS Uddin, A Al Mamun, MT Kabir, M Jakaria, B Mathew, GE Barreto, ...
Molecular neurobiology 56 (7), 4925-4944, 2019
562019
Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases
B Mathew, DGT Parambi, GE Mathew, MS Uddin, ST Inasu, H Kim, ...
Archiv der Pharmazie 352 (11), 1900177, 2019
552019
Exploration of chlorinated thienyl chalcones: A new class of monoamine oxidase-B inhibitors
B Mathew, A Haridas, G Uçar, I Baysal, AA Adeniyi, MES Soliman, M Joy, ...
International journal of biological macromolecules 91, 680-695, 2016
552016
Melatonin in Alzheimer’s disease: a latent endogenous regulator of neurogenesis to mitigate Alzheimer’s neuropathology
MF Hossain, MS Uddin, GMS Uddin, DM Sumsuzzman, MS Islam, ...
Molecular neurobiology 56 (12), 8255-8276, 2019
542019
Cholinesterase inhibitors for Alzheimer's disease: multitargeting strategy based on anti-Alzheimer's drugs repositioning
MT Kabir, M Uddin, M Begum, S Thangapandiyan, M Rahman, L Aleya, ...
Current pharmaceutical design 25 (33), 3519-3535, 2019
532019
Identification of Indole‐Based Chalcones: Discovery of a Potent, Selective, and Reversible Class of MAO‐B Inhibitors
R Sasidharan, SL Manju, G Uçar, I Baysal, B Mathew
Archiv der Pharmazie 349 (8), 627-637, 2016
512016
Heteroaryl chalcones: Mini review about their therapeutic voyage
B Mathew, J Suresh, S Anbazghagan, J Paulraj, GK Krishnan
Biomedicine & Preventive Nutrition 4 (3), 451-458, 2014
512014
Advancements in nanotherapeutics for Alzheimer’s disease: current perspectives
S Harilal, J Jose, DGT Parambi, R Kumar, GE Mathew, MS Uddin, H Kim, ...
Journal of Pharmacy and Pharmacology 71 (9), 1370-1383, 2019
502019
Monoamine oxidase inhibitory action of chalcones: A mini review
B Mathew, A Haridas, J Suresh, G E Mathew, G Uçar, V Jayaprakash
Central Nervous System Agents in Medicinal Chemistry (Formerly Current …, 2016
502016
Toxic tau: structural origins of tau aggregation in Alzheimer's disease
A Al Mamun, MS Uddin, B Mathew, GM Ashraf
Neural Regeneration Research 15 (8), 1417, 2020
492020
NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy
MT Kabir, MA Sufian, M Uddin, M Begum, S Akhter, A Islam, B Mathew, ...
Current pharmaceutical design 25 (33), 3506-3518, 2019
482019
Synthesis, biochemistry, and computational studies of brominated thienyl chalcones: a new class of reversible MAO‐B inhibitors
B Mathew, A Haridas, G Uçar, I Baysal, M Joy, GE Mathew, ...
ChemMedChem 11 (11), 1161-1171, 2016
472016
Monoamine oxidase inhibitory activity: methyl-versus chlorochalcone derivatives
B Mathew, G Uçar, GE Mathew, S Mathew, PK Purapurath, F Moolayil, ...
ChemMedChem 11 (24), 2649-2655, 2016
402016
Emerging signal regulating potential of small molecule biflavonoids to combat neuropathological insults of Alzheimer's disease
MS Uddin, MT Kabir, D Tewari, B Mathew, L Aleya
Science of the Total Environment 700, 134836, 2020
392020
Development of fluorinated thienylchalcones as monoamine oxidase-b inhibitors: Design, synthesis, biological evaluation and molecular docking studies
B Mathew, G Ucar, S Yabanogclu-Ciftci, I Baysal, J Suresh, ...
Letters in Organic Chemistry 12 (9), 605-613, 2015
382015
Monoamine oxidase inhibitory activity of methoxy-substituted chalcones
B Mathew, GE Mathew, G Ucar, M Joy, EK Nafna, KK Lohidakshan, ...
International journal of biological macromolecules 104, 1321-1329, 2017
372017
Pyrazoline: A promising scaffold for the inhibition of monoamine oxidase
B Mathew, J Suresh, S Anbazhagan, G Elizabeth Mathew
Central Nervous System Agents in Medicinal Chemistry (Formerly Current …, 2013
372013
The system can't perform the operation now. Try again later.
Articles 1–20